Manulife (Manufacturers Life Insurance)
TPST icon

Manulife (Manufacturers Life Insurance)’s Tempest Therapeutics TPST Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$1K – 4336
2017
Q2 		– Hold
0
– – – 4258
2017
Q1 		– Sell
-2
Closed -$9.31K – 3960
2016
Q4 		$10K Sell
2
-6
-75% -$74.7K ﹤0.01% 3770
2016
Q3 		$166K Hold
8
– – ﹤0.01% 2912
2016
Q2 		$124K Buy
8
+2
+33% +$45.7K ﹤0.01% 3107
2016
Q1 		$154K Buy
6
+1
+20% +$21.1K ﹤0.01% 2783
2015
Q4 		$155 Hold
5
– – ﹤0.01% 2847
2015
Q3 		$132 Sell
5
-23
-82% -$1.55M ﹤0.01% 2982
2015
Q2 		$2.35K Buy
28
+24
+600% +$2.2M ﹤0.01% 1373
2015
Q1 		$392 Buy
4
+1
+33% +$133K ﹤0.01% 2231
2014
Q4 		$440 Hold
3
– – ﹤0.01% 2062
2014
Q3 		$165 Buy
+3
New +$105K ﹤0.01% 2767
2014
Q2 		– Sell
-1
Closed -$23.6K – 3709
2014
Q1 		$28 Sell
1
-1
-50% -$28.3K ﹤0.01% 3269
2013
Q4 		$41 Sell
2
-1
-33% -$27.4K ﹤0.01% 3228
2013
Q3 		$76 Hold
3
– – ﹤0.01% 3089
2013
Q2 		$105K Buy
+3
New +$113K ﹤0.01% 2995

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TPST Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) held its Tempest Therapeutics (TPST) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

Manulife (Manufacturers Life Insurance) first reported a position in TPST in Q2 2013 and has held it in 14 quarters since. The position peaked at $166K in Q3 2016. 47 funds tracked by Wall St. Rank hold TPST as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) held 0 shares of Tempest Therapeutics worth $0 as of Q3 2017.
  • Manulife (Manufacturers Life Insurance) left its Tempest Therapeutics share count unchanged in Q3 2017.
  • Tempest Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q3 2017, its #4336 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tempest Therapeutics in Q2 2013 and has held it in 14 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Tempest Therapeutics position peaked at $166K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.